Abstract:e15613 Background: Synchronous multifocal tumors are invariably seen in hepatobiliary and pancreatic cancer, however, because of the similar histological features, it is hard to identify the precise tissue clonal origin of the different lesions through routine pathologic diagnosis. Herein, we use genome-wide copy number variation (CNV) platform to explore the situation. Methods: CNV data of 598 cancer samples across hepatocellular cancer , cholangiocarcinoma and pancreatic cancer were compiled from The Cancer Genome Atlas dataset. We use Cancer Browser to structure their heatmaps and randomly allocated them to the training or test sets. A 10-fold cross-validation method was used to train the model on 9-fold and test it on the remaining 1-fold. GISTIC 2.0 extracted the landmark CNV events for each cancer. Stepwise logistic regression was performed to generate corresponding signature. Finally, the model was verified by two patients with synchronous multifocal hepatobiliary and pancreatic tumors. Results: The above algorithms showed CNV platform had good tissue specificity, yielding high sensitivity (91.4% ± 4.05%) and specificity (96.7% ± 2.49%) for analysis of tissue clonal origin in hepatobiliary and pancreatic cancer. When it came to clinical application, the model yielded an accuracy of ≥90%.The first application is a patient suffered from multiple nodules in pancreatic tail, upper biliary duct and omental. CNV analysis identified two different clones. Model matching found that the tumors in biliary duct and omental originated from the common biliary duct while the pancreatic lesion was originated just from pancreas. Another application is a patient who had multiple nodules in left liver, pancreas and abdominal lymph nodes. Unlike the first patient, CNV analysis showed these tumors belonged to the same clone. Model matching then proved it a clone of intrahepatic cholangiocarcinoma. Conclusions: We demonstrate a CNV computational model to accurately identify tissue clonal origin for synchronous multifocal hepatobiliary and pancreatic cancer. It is more meaningful that the model itself might be extended to other cancer types, as well as its diagnostic value for the cancer of unknown primary.

The Repertoire of Copy Number Alteration Signatures in Human Cancer

Systematic Modeling of Risk-Associated Copy Number Alterations in Cancer

Copy Number Aberrations from Affymetrix SNP 6.0 Genotyping Data-How Accurate Are Commonly Used Prediction Approaches?

Signatures of copy number alterations in human cancer

The Study on Copy Number Alteration of Clear Cell Renal Cancer in Chinese Population

Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes

Copy number alteration features in pan-cancer homologous recombination deficiency prediction and biology

Identification of Prognostic Biomarkers of Hepatocellular Carcinoma Via Long Noncoding RNA Expression and Copy Number Alterations.

The Landscape of Somatic Copy Number Alterations in Head and Neck Squamous Cell Carcinoma

A CNV Computational Model for Clonal Origin Analysis of Synchronous Multifocal Hepatobiliary and Pancreatic Tumors.

Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors

Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer

TAGCNA: A Method to Identify Significant Consensus Events of Copy Number Alterations in Cancer

CaSNP: a Database for Interrogating Copy Number Alterations of Cancer Genome from SNP Array Data

Identification and Analysis of Sex-Biased Copy Number Alterations

Comparative Analysis of Methods for Identifying Recurrent Copy Number Alterations in Cancer.

The landscape of somatic copy-number alteration across human cancers

Classification of cancers based on copy number variation landscapes

Combined analysis with copy number variation identifies risk loci in lung cancer.

Genome-wide Somatic Copy Number Alteration Analysis and Database Construction for Cervical Cancer.

Single-cell sequencing deciphers a convergent evolution of copy number alterations from primary to circulating tumor cells.